Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $309.82M | $178.99M | $221.70M | $336.01M |
| Net Income | -$95.15M | -$170.06M | -$124.13M | -$57.54M |
| EPS Diluted | -$0.39 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| -$0.72 |
| -$0.54 |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.